The next three years were essentially one long growth spurt. March 2023 brought GPT-4, which made ChatGPT noticeably sharper, ...
Apparently, there are a couple of LLMs which are gaining traction with cybercriminals. That's led researchers at Palo Alto ...
Novo Nordisk faces setbacks with semaglutide in Alzheimer's trials and declining growth. Read here for analyst outlook and why NVO stock is rated Hold now.